Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.095 EUR | -1.41% | +8.21% | +45.49% |
Apr. 12 | Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin... | |
Apr. 12 | NFL Biosciences: successful capital increase | CF |
Sales 2023 | 200K 216K | Sales 2024 * | - | Capitalization | 17.23M 18.58M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 86.1 x |
Net cash position 2023 * | 2.3M 2.48M | Net cash position 2024 * | 200K 216K | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.13% |
1 day | -1.41% | ||
1 week | +8.21% | ||
Current month | +13.86% | ||
1 month | +3.71% | ||
3 months | +3.71% | ||
6 months | +42.13% | ||
Current year | +45.49% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Lafont
FOU | Founder | - | 06-08-31 |
Ignacio Faus
CEO | Chief Executive Officer | - | 21-05-18 |
Guillaume Audema
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yannick Plétan
BRD | Director/Board Member | - | 21-05-18 |
Ignacio Faus
CEO | Chief Executive Officer | - | 21-05-18 |
Bruno Lafont
FOU | Founder | - | 06-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 2.095 | -1.41% | 19 647 |
24-05-13 | 2.125 | +3.66% | 94,242 |
24-05-10 | 2.05 | +0.24% | 26,405 |
24-05-09 | 2.045 | -0.49% | 21,530 |
24-05-08 | 2.055 | +6.15% | 59,753 |
Real-time Euronext Paris, May 14, 2024 at 04:20 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.49% | 18.59M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.39% | 21.93B | |
-12.15% | 22.34B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ALNFL Stock